Literature DB >> 1718848

Characterization of B cells in human thymus.

T Kumamoto1, M Inaba, H Imamura, K Nango, Y Adachi, S Than, K Inaba, T Kagawa, S Ikehara.   

Abstract

The surface characteristics of B cells present in the human thymus were investigated. Cytofluorometrical and immunohistological studies, using anti-human IgM or anti-B cell monoclonal antibodies (mAbs; anti-Leu 12Ab, anti-Leu 16Ab, or L26), revealed that a small number of B cells are present in the human thymus. The thymic B cells were detected only in a low-density cell population, whereas in a high-density cell fraction, only T cells were found. In 15 cases, all of which the thymi were histologically normal, the percentages of B cells in the low-density fraction were 0.28% to 50% (6.8% in average), and Leu 1+ (CD5+) B cells in the low-density fraction were 0.1% to 26% (3.5% in average); approximately 50% of the thymic B cells were Leu 1+ B cells. These results indicate that B cells, especially Leu 1 (CD5)+ B cells, are also present in the human thymus, as suggested from our previous reports on mice.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1718848     DOI: 10.1016/s0171-2985(11)80188-9

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  3 in total

1.  T cell-B cell thymic cross-talk: maintenance and function of thymic B cells requires cognate CD40-CD40 ligand interaction.

Authors:  Chiharu Fujihara; Joy A Williams; Masashi Watanabe; Hyein Jeon; Susan O Sharrow; Richard J Hodes
Journal:  J Immunol       Date:  2014-10-24       Impact factor: 5.422

2.  T Cell/Histiocyte-Rich Large B Cell Lymphoma of the Thymus: A Diagnostic Pitfall.

Authors:  Jie Xu; Xiaojun Wu; Vishnu Reddy
Journal:  Case Rep Hematol       Date:  2016-01-20

Review 3.  The Multifaceted Roles of B Cells in the Thymus: From Immune Tolerance to Autoimmunity.

Authors:  Justine Castañeda; Yessia Hidalgo; Daniela Sauma; Mario Rosemblatt; María Rosa Bono; Sarah Núñez
Journal:  Front Immunol       Date:  2021-11-01       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.